Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Pharmaceuticals for Targeting Coronaviruses
    Pharmaceuticals for Targeting Coronaviruses
    Pharmaceuticals for Targeting Coronaviruses
    Ebook338 pages3 hours

    Pharmaceuticals for Targeting Coronaviruses

    By Bentham Science Publishers

    ()

    Read preview

    About this ebook

    This reference summarizes information about pharmaceuticals that can target infectious strains of coronaviruses to neutralize infections. Chapters focus on SARS-CoV-2, drug discovery methods and natural methods to combat the virus, which is a causative agent of COVID-19.
    Specifically, the book presents 5 chapters written by expert scholar on the following topics:
    Structure-Based Drug Discovery Approaches Applied to SARS-CoV-2 (the causative agent COVID- 19)
    Potential Antiviral Medicinal Plants against Novel SARS-CoV-2
    Infections Caused by SARS Coronaviruses: Main Characteristics, Targets And Inhibitors
    Natural Sourced Traditional Indian and Chinese Medicines to Combat COVID- 19
    Peptidomimetic and Peptide-Derived Agents Against 3CLpro from Coronaviruses
    The book contents present both conventional drug design and traditional approaches to discovering relevant drugs in an easy-to-read approach, which is supplemented by bibliographic references. It is intended as a reference for students (pharmacology, pharmacy) and researchers (virology) who are seeking information about antiviral drugs that can be used against coronaviruses.

    LanguageEnglish
    PublisherBentham Science Publishers
    Release dateJul 31, 2001
    ISBN9789815051308
    Pharmaceuticals for Targeting Coronaviruses

    Related to Pharmaceuticals for Targeting Coronaviruses

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Roundup: EPA Releases Several Rules and a Draft Scientific Integrity Policy

      Apr 17, 2024

      In this latest scientific integrity roundup, a preview of Supreme Court cases that could limit federal agencies' ability to set protective standards.

      5 min read

    • Article

      Dr. William Levine

      Jan 3, 2020

      Dr. William Levine
      5 min read

    • Article

      Sanofi Announces It Will Work With HHS To Develop Coronavirus Vaccine

      Feb 18, 2020

      Sanofi said it expects to have a coronavirus vaccine candidate — a prototype — to test in vitro within six months and could be ready to test the vaccine in…

      3 min read

    • Article

      Opinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine

      Oct 2, 2018

      When it comes to #microbiome medicine, @US_FDA and @NIH need to create a solid, science-based regulatory framework to help realize the promise of living drugs.

      4 min read

    • Article

      An Updated Guide To The Coronavirus Drugs And Vaccines In Development

      Mar 19, 2020

      In the months since the novel coronavirus rose from a regional crisis to a global threat, drug makers large and small have scrambled to advance their best ideas for thwarting a pandemic. Some are taking a cue from older antivirals. Some are tapping t

      6 min read

    • Article

      Covid Vaccines Compared: What Are The Differences Between Pfizer, Moderna, Oxford-AstraZeneca And Novavax? OLD

      Feb 16, 2021

      After almost a year in which the entire world has been paralysed by coronavirus, a way out is finally in sight through the Covid-19 vaccines. The past few months have brought positive news of candidates from Pfizer, Moderna, Oxford University with As

      10 min read

    • Article

      Covid Vaccines Compared: What Are The Differences Between Pfizer, Moderna, Oxford-AstraZeneca And Novavax? - OLD

      Mar 2, 2021

      After almost a year in which the entire world has been paralysed by coronavirus, a way out is finally in sight through the Covid-19 vaccines. The past few months have brought positive news of candidates from Pfizer, Moderna, Oxford University with As

      10 min read

    • Article

      Covid Vaccines Compared: What Are The Differences Between Pfizer, Moderna, Oxford-AstraZeneca And Novavax?

      Apr 13, 2021

      After almost a year in which the entire world has been paralysed by coronavirus, a way out is finally in sight through the Covid-19 vaccines. The past few months have brought positive news of candidates from Pfizer, Moderna, Oxford University with As

      10 min read

    • Article

      Former Novartis Exec Wants To Repurpose Generic Drugs To Fight Covid-19

      Apr 7, 2020

      As Covid-19 sweeps the globe, a growing number of efforts are underway to quickly research and develop treatments and vaccines. Yet much of the work is disjointed and widespread access to any medical product is uncertain. One idea, suggested by Costa

      5 min read

    • Article

      Letters

      Dec 13, 2020

      THE Durban University of Technology (DUT) has noted the story related to a reported Covid-19 breakthrough that was published in the Sunday Tribune, Weekend Argus and on iol.co.za, December 7, 2020. In response we would like to make the following comm

      2 min read

    • Article

      The Case For Drug Repurposing

      Nov 9, 2020

      Dr Markus Depfenhart, a specialist in plastic and aesthetic surgery According to the WHO, as of 14 July 2020, there have been more than 13 million confirmed cases of COVID-19 globally, and close to 600 000 deaths. We are in dire need of strategies to

      2 min read

    • Article

      It Has Been A Race Which Has Transformed Vaccines: DOCTORS ARE READY TO GIVE VACCINE 2.0

      Mar 31, 2021

      Physician Ugur Sahin received an email late one Friday night near the end of January 2020. At the time, very few people had realised that a new coronavirus was about to take the world’s population in its grip. But as Sahin read the scientific article

      6 min read

    • Article

      What To Know About Vaccines

      Nov 20, 2020

      What To Know About Vaccines
      4 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Covid Vaccines Compared: What Are The Differences Between Pfizer, Moderna, Oxford-AstraZeneca And Novavax? - OLD

      Jan 29, 2021

      After almost a year in which the entire world has been paralysed by coronavirus, a way out is finally in sight through the Covid-19 vaccines. The past few months have brought positive news of candidates from Pfizer, Moderna, Oxford University with As

      9 min read

    • Article

      Opinion: ‘One-and-done’ For New Drugs Could Cut Patent Thickets And Boost Generic Competition

      Feb 11, 2019

      Instead of patenting new drugs, companies are recycling old ones to build insurmountable patent walls. We can fix that with a "one-and-done" approach that gives each drug one, and only…

      4 min read

    • Article

      Will Congress Turn Its Back on the Safety of America’s Workers?

      Mar 16, 2017

      Let’s say someone you care about—mother, father, wife, husband, partner, son, daughter, friend, and neighbor—works in a facility that’s had a history of serious injuries or illnesses. You know, like burns, amputations, and broken bones that happen at

      3 min read

    Reviews for Pharmaceuticals for Targeting Coronaviruses

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Pharmaceuticals for Targeting Coronaviruses - Bentham Science Publishers

      r|bbook_preview_excerpt.html\ێvA$hHΌ4ad.%Ie`"YGn/3 'O'/{׭Aڵk_־T˦rռj3֍mݭԭm;u֦֕ňRwMxnxry|1K\Uj~wW?otٍ/_#~mRMW/Unϝ-+ynlWkSU-_UM{бjHnfcN2W׶jM.Z˲im۵frSB}_ZpNUKuU6݌ku?B^EU붪&-1QXwޮu]k32Ϭ)3zx|u:k#J8A_`i6ި3*ʆ̍n׍uՁ]ڨ.muӎ]^~-?Mj˼/XUa̍,!+;kumY0u4G\cZ5]jeUkm &̪l " .Pu6jaLjjZ{osJekP5[z =Rd?mb@;Gv xGjtB@HF\ڰN%6%TRidke'9L[@\Vn8#( k]hz~6:x>ٿmW5M'bȉ&Vvn9~qwr5USA[( 9xXE<ǛAEĩNOuch#Chif2'/wsg٘{3NgPVL}oΖ8.SZBC2XRMn:uzkt4OrH]Qmz<mmA*׻* -0 G,rX.xD,I뼥|qL٘zBH/rcrPH^㎵2䑅 Qr8"W I44k8ێ T@vH': &$ބJNF&Gl9S^o(ӱ0IV2  \ϪCr44`W++s8U"I÷՜:Q7S]>qdy/*HD*+J&ǝaá%R~ɹ5<#ncCL@ 3E=r:Xіeu HX¢Q.,'΋?'0p^d(~aoGaw-وgT)gـvQeɫ#NrJЮ ѓMAP7r$KC K0(o<я/;&^fd5xVxIWs>6 8ppJn(yZQG'Ǵ14hzq1:~,ma٣e~.mm4$F;Vv:<%Z ,@n7:78 lJc>'aMkRù֘(6F486{ @8 UyWώ7Շ ria^g:# y۪ f>aO f7cly% j^"x|^p b FBl+mPmL .`H=M'T|atrVdWU]ma?JQ%%΂ L&r 8?sBY *ek bti7[ٍ1B Өh K zߑp6D:Vt8̮9R^ a_3vѵ.-2ga# ]XY#809\ p,sr1_.BRn"c; +|vBH1>>&e0NGG_x%KNk-]wK'įĽB7cpԱdDŽ~ [ q^ Q 3,~8&<Lp)Q 1ӈ~F6DH`Ota5H3m82[0^7n=Z)\ Q6'kd/y,zeXCLfA7`jNuwJI39~~li }'W+ XSqB@N  `DQESE``&ȓOV | ;hrk@1 & "Nѵ %LiyU:A5&/~8'5e}W!zIFmH}$-|A!*':xSsSGoߞ{e)YD<|b2tLxDFހ@jI+EZFΧ'Sr+eD{%kC $z2< !lnZL6g? xVh?)h?$ߋH!51 E锜ĿccK. #yajD FJP&4>vJ neiXc!&>-D !r0J㼁 0ı>-$H"J=11s,I rO$$Pt6-smM`4 %Iܿ5-QE-L2Ip?Z ^:+h/9P%AF1+m}17a(셜I0rI$/Z[eU8yorrEdSѩTO4ѕ my͏b omQ,`rkH)⦎ޕ]V*quzPb#~dH@KL]XL7;vL9*ho]Ê2KTU|7s ^~!hyNC:E5J]#L?bGI'6Y,JʋDIJxdЬ1N n/8xH:Az 3}eJn^άݿe=-{+;4/߽fkJrVԹ<]nO#|3t`ȑpJN\Ѓgo'(d1Dԛ].JȹCуQ[Ǹga.%g9(ʆLd!`\ivb(#CY(al0lޙrG$Ţ,I& 1"䄁a0 ͢Y0eQdXF~~[p","(-DVd s|g .k ;5U@0x%_F'9*T78pF咕i(t8qp I}^zbȢQw!UG vhhԌ ܴHL#FX ~8$|` T 4~_q Tչad5:bR;'9); %NXI!i_-ZiNb7r6|IS\QR 4:9 "&orOK?hMN.)*H}5)+MEEjI]LK_~WI7,堪J".*nǩZ{Cx x V{)nQ%DPJ"YT^0ݩ ws[`B1_#+g5'}9*o^5|s_k‰({W9H{-\Aʪ"4Ur+E8Zz컎]m^wUȦ-˽*k|< RbS}iHhs'*K=p зiB'HknGN9Of~S$tg&UNJsš# !?i+%J tM'uJW+r1fsILfпʅ1m)[X20{T)~f("bL4p̪i)] kԟ:jmn&]y{jnџ;.,Wn\vEZPPmOki/m|R9uY, eļ^L~pOkxAeDViEW.Dϒ&8Jg1w\K_>sFV9;&'O">kMHk">X"g&HrՉYk[_5tkuZ>NkT~AEP&a肈||]x6jHȍAbLMπQK1zbc@BxVL+/P'YO]Mf0.Q_KG&yݞ!fo(Ѓn՜bH / !)> };34gsysdj 98hDpQIKj`hd*A!"___)9r|n-yb#Π.Ee( ʥQKCcӁeg|E}lLf kJ,$I Ik]dv(Sl̶pF<)CWE?9 ?(QJy[ '6v)ZݩʵI!_qKr1uMJh;q瀹uz*)qChp;e&|w Н@z,ʢhу` @HʲG]=wu@J(%4cAJxx F/NM>ɠAӐ:'!h@,!I{A z߸g Oo]-VDԙ˭ z.7^9olJ0H6;vlxZ wQl.%ƪr@=NJۂ}B\" oҒDC E!zG ň k}s2[Փz@wtR j#̲_=t.%5ѻ<ߙQ |HEe:IRؒn UD?.Jw^$l ~Ifc6￙#\._\hv1<(JLZC@4O ۽ֱ?R`VdJ  W}{I=-`XdĂorJr|;Q &4swrGlR]TvxA>ԣ~Fk?]^нvGWuƐPhNK7$㙖Wl*MQ׷lgZ*w&wÜ%՚ѝ$R̋l.v +oHu~r}"ʯOo`Çx74s-SG@~`SIR u7GL~ 5zcʢ@mqItfU. !;Nr/JboV: a u{HzYSF*qO&oOKA3$=7=,2mf؊0{யP±C&Hʅ9g[VIo~ZHfuCDr'|Y@ )Q^QFVTtG]#² 3SߧSwcfq3^ucW +oӡMf>Kg>ZC=Z}̒.'lȐİKB$cuF]qnot_vu`dei.4%nt'zHMql6&JU5ұi颳^h6',ol12{%59G!~+<%@#^D#i{сIrK}W|4K)Xs$WB5KrW +\E:*]IY\-LpdzT}z! 2p|rKXan#u} 'p&礼_ӣ^aMZ&I BW\Gt^dr$/ ? } ,96tzm\chY0xȃ@72dc.=Va'-&>\HٓCn]'r}EA]$w8COVTTNLYݺumV!=,BoAjz M=PYkViB `7t6Qyf}J>[/#;83ټJӴZT{sj&"EQ1dFz92ﲋ/-|J!$yf:l{P k bZ^I^A5(=hl<*<.)TƸUj)Zr`paH9L.QåGzq}3|候kBN >KԸnx2[.kOEQ[ӷ;r k- Z_H[I1Q9Si=y_2-{l/ƋߑWLBX
      Enjoying the preview?
      Page 1 of 1